ROZLYTREK

Identification of Rozlytrek

No description

Google image searchProduct monograph

Active ingredient

entrectinib, 200 MG

DIN: 02495015

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: HOFFMANN-LA ROCHE LIMITED

Date: 04-MAR-2020

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
• L01EX14 — ENTRECTINIB (ATC/DDD)

Reference brand drug: Rozlytrek

External Links for Rozlytrek

Search on Google

• Rozlytrek side effects
• Rozlytrek dosage
• entrectinib side effects
• entrectinib dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find rozlytrek photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.